Stock Scorecard

Stock Summary for Hepion Pharmaceuticals Inc (HEPA) - $0.28 as of 5/3/2025 1:27:52 AM EST

Total Score

8 out of 30

Safety Score

23 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for HEPA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for HEPA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for HEPA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for HEPA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for HEPA (23 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for HEPA

Hepion Pharmaceuticals Announces Reverse Stock Split 3/14/2025 12:30:00 PM
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aditxt ( NASDAQ:ADTX ) , American Eagle Outfitters ( NYSE:AEO ) 3/13/2025 9:05:00 AM
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales - Abbott Laboratories ( NYSE:ABT ) , Absci ( NASDAQ:ABSI ) 1/22/2025 7:39:00 PM
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings - Absci ( NASDAQ:ABSI ) , Agilysys ( NASDAQ:AGYS ) 1/22/2025 4:59:00 PM
US Stocks Higher; Netflix Profit Beats Estimates - Asset Entities ( NASDAQ:ASST ) , Blackboxstocks ( NASDAQ:BLBX ) 1/22/2025 2:45:00 PM
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd. 12/11/2024 1:00:00 PM
Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson's Disease Study Group - Hepion Pharmaceuticals ( NASDAQ:HEPA ) 12/5/2024 1:30:00 PM
Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B 12/2/2024 1:00:00 PM
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Deckers Outdoor ( NYSE:DECK ) 10/25/2024 10:05:00 AM
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger 9/4/2024 1:25:00 PM

Financial Details for HEPA

Company Overview
Ticker HEPA
Company Name Hepion Pharmaceuticals Inc
Country USA
Description Hepion Pharmaceuticals, Inc., a biopharmaceutical company, is focused on developing drug treatments for chronic liver disease in the United States. The company is headquartered in Edison, New Jersey.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 3/31/2025
Next Earnings Date 5/19/2025

Stock Price History
Last Day Price 0.28
Price 4 Years Ago 1,140.00
Last Day Price Updated 5/3/2025 1:27:52 AM EST
Last Day Volume 20,383,099
Average Daily Volume 7,771,299
52-Week High 77.50
52-Week Low 0.25
Last Price to 52 Week Low 12.00%

Valuation Measures
Trailing PE N/A
Industry PE 32.04
Sector PE 37.03
5-Year Average PE -107.07
Free Cash Flow Ratio 7.00
Industry Free Cash Flow Ratio 19.19
Sector Free Cash Flow Ratio 29.42
Current Ratio Most Recent Quarter 0.51
Total Cash Per Share 0.04
Book Value Per Share Most Recent Quarter -25.57
Price to Book Ratio 2.11
Industry Price to Book Ratio 7.60
Sector Price to Book Ratio 21.93
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 101.19
Sector Price to Sales Ratio Twelve Trailing Months 28.34
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 10,975,300
Market Capitalization 3,073,084
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 73.04%
Reported EPS 12 Trailing Months -5,367.50
Reported EPS Past Year 0.00
Reported EPS Prior Year -14.94
Net Income Twelve Trailing Months -11,886,068
Net Income Past Year -13,192,420
Net Income Prior Year -48,926,042
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 406,408
Total Cash Past Year 406,408
Total Cash Prior Year 14,785,880
Net Cash Position Most Recent Quarter -1,699,345
Net Cash Position Past Year 406,408
Long Term Debt Past Year 0
Long Term Debt Prior Year 176,585
Total Debt Most Recent Quarter 2,105,753
Equity to Debt Ratio Past Year 0.00
Equity to Debt Ratio Most Recent Quarter -7.69
Total Stockholder Equity Past Year -1,863,338
Total Stockholder Equity Prior Year 7,280,807
Total Stockholder Equity Most Recent Quarter -1,863,338

Free Cash Flow
Free Cash Flow Twelve Trailing Months -15,752,384
Free Cash Flow Per Share Twelve Trailing Months -1.44
Free Cash Flow Past Year -18,230,607
Free Cash Flow Prior Year -40,903,182

Options
Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.52
MACD Signal -0.71
20-Day Bollinger Lower Band -10.82
20-Day Bollinger Middle Band 9.39
20-Day Bollinger Upper Band 29.60
Beta 1.80
RSI 21.23
50-Day SMA 290.59
150-Day SMA 0.00
200-Day SMA 532.86

System
Modified 5/3/2025 1:27:53 AM EST